Mobi Health News
FEBRUARY 14, 2019
Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million.
Health Populi
JANUARY 22, 2020
In pharma and biotech, those “experts” would be scientists doing R&D and those folks who understand the data underneath the discoveries. To that point, note that Edelman found in last year’s Trust Barometer that biotech was held to a much higher trust level than pharma within the larger healthcare industry segment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
APRIL 3, 2023
Together with our partners from the École Polytechnique Fédérale de Lausanne, the University of Geneva and Geneva University Hospital, the Wyss Center is poised to catalyze the unique concentration of world-class brain health research at Campus Biotech to drive clinical breakthroughs.”
Society for Participatory Medicine
JANUARY 27, 2022
Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. My mission of advocacy was widened and deepened upon my stage IV colorectal cancer diagnosis in 2014 when I shared my expertise with others fighting for scans and treatments.
Lloyd Price
DECEMBER 8, 2018
Craig Venter in 2014—at around $310 million, according to a Human Longevity regulatory filing obtained by Lagniappe Labs LLC, whose Prime Unicorn Index tracks valuations of privately held companies. Existing investors include biotech giant Celgene Corp. , The funding round values the company—co-founded by genomics pioneer J.
Lloyd Price
NOVEMBER 2, 2018
Pfizer aims to invest $150 million in biotech startups focused on neurometabolic disorders, neurodegeneration, and neuroinflammation. The DDF was founded in 2014 and has backers that include the AARP, the NFL Players Association, U.K.
Lloyd Price
FEBRUARY 13, 2024
The biotech company is a spin-out of the University of Dundee and develops targeted protein degradation medicines, which have the potential to treat serious diseases that currently have limited treatments. These initiatives are helping to create a supportive environment for healthtech companies to thrive. "At
Expert insights. Personalized for you.
157 
Let's personalize your content